INTRODUCTION AND OBJECTIVES: Adding systematic cores to MRI-targeted biopsy might improve the detection of clinically significant Prostate Cancer (PCa). Nonetheless, the implications of adding systematic cores in predicting adverse pathology in men undergoing radical prostatectomy (RP) are still unknown. METHODS: Overall, 659 patients who underwent MRI-targeted biopsy and RP between 2016 and 2018 at five referral centers were identified. All patients received concomitant systematic biopsy at the time of targeted biopsy. The D'Amico risk groups and the rate of pathological upgrading were assessed considering grade group at targeted biopsy and after adding information from systematic biopsy. A logistic regression model assessed the impact of MRI-targeted biopsy parameters (PSA, prostate volume, grade group at target biopsy, clinical stage and the diameter of the mpMRI lesion) on the risk of upgrading. A model that included also information on clinically significant PCa outside the index lesion, the number of random positive and total cores was developed. Their discrimination was compared using the area under the curve (AUC).
RESULTS: Median PSA was 7.8ng/ml. Targeted biopsy grade group was 1, 2, 3, and !4 in 86 (13%), 325 (49.3%), 138 (20.9%) and 110 (17%) patients. When considering also systematic cores, biopsy grade group was 1, 2, 3, and !4 in 60 (9%), 333 (50%), 145 (22%) and 121 (18%) men. Overall, 86 (13.1%), 445 (67%) and 128 (19%) patients had low-, intermediate-and high-risk disease at targeted biopsy. When considering information from systematic biopsy, 42 (6.4%), 451 (68%) and 166 (25%) patients had low-, intermediate-and high-risk. While 40 (46%) low-risk patients were reclassified as intermediate-risk, 5 (5.8%) and 33 (7.4%) low-and intermediate-risk patients were reclassified as high-risk. Upgrading decreased from 32% for targeted biopsies to 28% when including information from systematic biopsy (P[0.04). Significant disease at systematic biopsy and a higher number of systematic cores taken were associated with a reduced risk of upgrading (all P 0.01). The discrimination of a model predicting upgrading including systematic biopsy information was higher compared to including targeted biopsy only (AUC: 78 vs. 72%).
CONCLUSIONS: Adding systematic biopsy to targeted cores reduces the risk of upgrading. Our data reinforce the need for accurate systematic biopsy sampling to improve accuracy for tumor grading and to optimize patient selection for active surveillance or focal therapies.
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PD17-12 FREQUENCY OF DOWNGRADING FROM MR/US FUSION BIOPSY TO RADICAL PROSTATECTOMY BASED ON ISUP 2014 GRADING MODIFICATIONS
Matthew Truong*, Vishnu Kadiyala, Thomas Osinksi, Alexis Steinmetz, Zhiming Yang, Gary Hollenberg, Eric Weinberg, Changyong Feng, Edward Messing, Hiroshi Miyamoto, Thomas Frye, Rochester, NY INTRODUCTION AND OBJECTIVES: The introduction of MR/US fusion biopsy has led to increased detection of clinically significant prostate cancer. Less certain are the concerns of prostate cancer oversampling and potential overgrading at diagnosis. Based on the ISUP 2014 modifications, Grade Group (GG) should be assigned to each separate core at the time of biopsy and based on the "dominant nodule" at radical prostatectomy (RP). While the highest GG on any given core is frequently used for pre-treatment risk stratification, this definition has not yet been validated in the era of MR/US fusion biopsy. In this study, we sought determine how frequently downgrading occurs from MR/US fusion biopsy to RP based on the latest ISUP 2014 modifications.
METHODS: A retrospectively maintained multiparametric MRI database (n [ 1,161) was queried to identify 94 patients who underwent MR/US fusion biopsy followed by RP from January 1, 2015 to February 28, 2018. Biopsy cores and RP specimens were re-reviewed by a genitourinary pathologist to assign GG based on ISUP 2014 modifications. The highest GG of any core found on 12-core systematic biopsy (SB), targeted biopsy (TB), and SBþTB were compared for concordance against the GG of RP specimens.
RESULTS: Using the highest GG on any given core to define overall GG, upgrading at RP was observed in 44/94 (46.8%), 32/94
